| abstract |
The present invention relates to a novel therapeutic compound of formula (1) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, the use of said compound as a medicament, and the use of said compound for the manufacture of a particular medicament: [Formula 1] Wherein, R 1 is selected from the group consisting of C 2 -8 alkyl, R 2 is independently selected from the group consisting of a C 1 -8 alkyl, R 3 are independently selected from the group consisting of hydrogen and C 1 -8 alkyl is selected, R 4 are independently selected from the group consisting of a C 1 -8 alkyl. The invention also relates to a method of treatment comprising administering the compound. The novel compounds are useful for the treatment of age-related diseases with insulin receptor signaling dysfunction. |